PharmaNutra dividend and valuation

PHN · Borsa Italiana · EUR

Compare PharmaNutra
€86.80Change from previous close: +0.93%Absolute change: +€0.80

Close · November 17, 2026

Valuation

PharmaNutra paid €1.20 per share in dividends over the last 12 months (yield 1.4%). Last ex-dividend date: May 4, 2026. The P/E ratio is 35.0. The average price target of 3 analysts is €96.00.

Data as of November 16, 2026

PharmaNutra compared with similar companies

PharmaNutra's P/E (trailing 12 months): 35.0, +86% against the median of a group of 9 similar companies (18.8).

PharmaNutra's metrics compared with similar companies
MetricPharmaNutraMedian25th–75th percentileBand
P/E (trailing 12 months)35.018.817.4 – 25.5High
Forward P/E25.217.914.6 – 22.2High
EV/EBITDA21.712.38.98 – 15.2High
Price/book10.42.771.76 – 3.31High
Price/sales5.342.202.00 – 4.02High
Gross margin48.2%65.2%35.7% – 77.1%Middle
Operating margin21.7%16.7%11.3% – 23.1%Middle
Net margin15.4%11.9%7.0% – 15.5%Middle
ROE32.4%15.4%7.6% – 16.8%High
Debt/equity0.260.330.22 – 0.71Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

PharmaNutra: valuation over time

On the latest fiscal year's earnings (2025), PharmaNutra's P/E today is 41.5, above the median of its last 9 fiscal years (26.8; between 17.1 and 53.0 from 2017 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (1.4%) is below the median of the last 9 fiscal years (1.8%).

PharmaNutra P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025€54.30€2.0926.0€1.202.2%
2024€54.40€1.7331.5€1.001.8%
2023€56.40€1.3342.5€0.851.5%
2022€62.30€1.5640.0€0.801.3%
2021€75.40€1.4253.0€0.710.9%
2020€37.60€1.4525.9€0.671.8%
2019€23.40€0.8726.8€0.462.0%
2018€15.10€0.8817.1€0.422.8%
2017€12.70€0.6220.4€0.332.6%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
€796.66M
Enterprise value
€784.5M
EV/revenue
5.25

Profitability and growth

ROA
16.2%
ROIC
22.4%
Revenue growth (year over year)
19.3%
Earnings growth (year over year)
48.1%

Financial health

Total cash
€25.12M
Total debt
€20.02M
Current ratio
2.11
Quick ratio
1.58
Altman Z-Score
9.86
Piotroski F-Score
5.00

Dividends

Annual dividend per share
€1.20
Dividend yield
1.4%
Payout ratio
50.4%
Ex-dividend date
May 4, 2026

Analysts and estimates

Average price target
€96.00
Median price target
€93.00
High price target
€103.00
Low price target
€92.00
Analysts with a price target
3
Consensus
Strong buy
Forward EPS
€3.31
EPS estimate, current year
€2.59

Shares and trading

Beta
0.20
Average volume
15.17K
Shares outstanding
9.58M
Float
3.24M
Institutional ownership
15.0%
Insider ownership
65.0%